725 / 1138
•
D95
(mean ± SD) was lower: 2.2±4.4% (to ITV) and 2.5±4.8%
(to PTV) when AXB used
•
Mean doses
were lower: 2.9±4.9% (ITV) and 3.7±5.1% (PTV)
•
Calculated AXB doses were significantly lower in
1 patient
(difference in ITV and PTV mean dose, as well as ITV and PTV
D95 ranged from 22% to 24%). However, the
end respiratory
phase GTV received at least 95% of the prescription dose
.
•
SABR is feasible for lung tumours ≤ 1 cm, with excellent local
control
SABR in tumors with diameter ≤1 cm
Louie AV, IJROBP 2014